| Breakdown | Dec 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 494.97M | 513.81M | 560.72M | 582.27M | 488.05M |
| Gross Profit | 80.30M | 222.02M | 240.81M | 247.87M | 224.80M |
| EBITDA | 47.91M | 36.79M | 60.13M | 70.15M | 62.34M |
| Net Income | 9.93M | 4.44M | 20.89M | 33.82M | 26.86M |
Balance Sheet | |||||
| Total Assets | 451.19M | 433.32M | 468.96M | 473.91M | 449.54M |
| Cash, Cash Equivalents and Short-Term Investments | 35.09M | 39.45M | 34.46M | 36.25M | 57.71M |
| Total Debt | 96.84M | 74.88M | 105.08M | 94.99M | 95.61M |
| Total Liabilities | 178.57M | 163.23M | 191.31M | 199.21M | 193.80M |
| Stockholders Equity | 267.50M | 264.35M | 271.72M | 264.60M | 243.27M |
Cash Flow | |||||
| Free Cash Flow | -5.49M | 42.93M | 14.69M | -1.81M | 43.80M |
| Operating Cash Flow | 6.31M | 51.21M | 32.18M | 10.69M | 51.70M |
| Investing Cash Flow | -18.96M | -6.33M | -21.75M | -10.41M | -31.99M |
| Financing Cash Flow | 16.28M | -47.47M | -12.21M | -21.88M | -11.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | €217.94M | 20.67 | 11.18% | 1.56% | 2.49% | 56.63% | |
68 Neutral | €154.44M | 10.53 | 8.29% | 1.82% | -34.69% | -17.06% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | €157.71M | 14.86 | 3.74% | 0.69% | -3.67% | 133.83% | |
55 Neutral | €383.37M | -3.68 | -16.86% | ― | -6.15% | -218.20% | |
55 Neutral | €163.32M | -37.36 | -2.41% | ― | -8.60% | -107.57% | |
49 Neutral | €154.51M | -13.10 | -4.16% | ― | 4.81% | 75.36% |